HemaSphere (Jun 2022)

P554: GILTERITINIB VERSUS SALVAGE CHEMOTHERAPY FOR RELAPSED/REFRACTORY FLT3-MUTATED ACUTE MYELOID LEUKEMIA: A PHASE 3, RANDOMIZED, MULTICENTER, OPEN-LABEL TRIAL IN ASIA

  • J. Wang,
  • B. Jiang,
  • J. Li,
  • L. Liu,
  • X. Du,
  • H. Jiang,
  • J. Hu,
  • M. Yuan,
  • T. Sakatani,
  • T. Kadokura,
  • M. Takeuchi,
  • S. Izuka,
  • L. Girshova,
  • J. Tan,
  • S. Bondarenko,
  • L. L. L. Wong,
  • A. Khuhapinant,
  • E. Martynova,
  • N. Hasabou,
  • R. Tiu

DOI
https://doi.org/10.1097/01.HS9.0000845104.07004.2e
Journal volume & issue
Vol. 6
pp. 453 – 454

Abstract

Read online

No abstracts available.